Related Experiment Video
Updated: Aug 20, 2025

08:54
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
7.8K
Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis - China, 2018-2020
Shunxian Zhang1, Lei Qiu1, Dingzhong Wu1
1Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
China CDC Weekly
|November 25, 2022
Summary
Early monitoring of multi-drug resistant tuberculosis (MDR-TB) using sputum and imaging can identify patients with poor outcomes. This allows for timely treatment adjustments to improve patient results and public health.
Area of Science:
- Public Health
- Infectious Diseases
- Medical Imaging
Background:
- Multi-drug resistant tuberculosis (MDR-TB) poses a significant global health challenge.
- Effective management of MDR-TB requires accurate prediction of treatment outcomes.
Purpose of the Study:
- To investigate the association between sputum cultures, lung imaging, and treatment outcomes in MDR-TB patients.
- To identify key indicators for predicting poor treatment outcomes in MDR-TB.
Main Methods:
- Retrospective analysis of MDR-TB patient data.
- Correlation of sputum culture results and lung imaging findings with treatment outcomes.
Main Results:
- Sputum cultures and lung imaging findings are strongly associated with MDR-TB treatment outcomes.
- These factors serve as a multi-dimensional approach to identify patients at risk of poor outcomes.
Conclusions:
- Early and consistent monitoring of sputum bacterium and lung imaging is crucial for MDR-TB patient management.
- Informing physicians about these indicators can lead to therapeutic schedule adjustments and improved treatment outcomes.
- Increased investment in monitoring MDR-TB patients, particularly through imaging and sputum analysis, is recommended for public health practice.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Pulmonary Tuberculosis I
297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis IV
186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K

